Dyschromatosis Universalis Hereditaria 1 C2675711
Dyschromatosis universalis hereditaria 1 is a genetic subtype linked to specific gene variations. It causes patches of lighter and darker skin to develop, usually starting in childhood. The condition is typically mild and does not affect overall health.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Comprehensive sun protection
Implementation of daily sun protection strategies including broad-spectrum sunscreen, UV-protective clothing, and sun avoidance during peak hours.
Topical treatment for pigmentation
Prescription topical medications applied to affected areas to help normalize skin coloration and reduce hyperpigmented patches.
Additional treatment options
Laser therapy evaluation
Specialist evaluation for laser treatment options that may help improve pigmentation uniformity in affected skin areas.
procedureCosmetic concealment
Professional-grade cover-up products and techniques to mask pigmentation irregularities for improved appearance.
complementaryLongitudinal skin monitoring
Regular skin examinations to track progression and evaluate effectiveness of treatment interventions over time.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Dyschromatosis Universalis Hereditaria 1 C2675711?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Tanaka M, Hayashi R, Suzuki H. Dyschromatosis Universalis Hereditaria: A Comprehensive Clinical and Genetic Review. J Dermatol Sci. 2018.
Zhang L, Wang Q, Chen J, Liu Y. Clinical Features and Genetic Analysis of 15 Families with Dyschromatosis Universalis Hereditaria. Orphanet J Rare Dis. 2020.
Japanese Dermatological Association. Guidelines for the Diagnosis and Management of Pigmentary Disorders Including Dyschromatosis. J Dermatol. 2022.
Puri N, Sharma A, Gupta R. Unusual Presentations and Variants of Dyschromatosis Universalis Hereditaria: A Systematic Review. Int J Dermatol. 2021.
Medication Comparisons
Compare medications used to treat Dyschromatosis Universalis Hereditaria 1 C2675711. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy